Autobio Diagnostics Co., Ltd. (SHA:603658)
China · Delayed Price · Currency is CNY 37.31
+0.47 (1.28%)
At close: Jan 23, 2026
Autobio Diagnostics Revenue
Autobio Diagnostics had revenue of 1.07B CNY in the quarter ending September 30, 2025, a decrease of -9.04%. This brings the company's revenue in the last twelve months to 4.22B, down -7.92% year-over-year. In the year 2024, Autobio Diagnostics had annual revenue of 4.47B with 0.62% growth.
Revenue (ttm)
4.22B
Revenue Growth
-7.92%
P/S Ratio
5.05
Revenue / Employee
730.70K
Employees
5,773
Market Cap
21.32B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.47B | 27.55M | 0.62% |
| Dec 31, 2023 | 4.44B | 2.03M | 0.05% |
| Dec 31, 2022 | 4.44B | 675.71M | 17.94% |
| Dec 31, 2021 | 3.77B | 787.79M | 26.45% |
| Dec 31, 2020 | 2.98B | 298.70M | 11.15% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Lepu Medical Technology (Beijing) | 6.26B |
| Shandong Weigao Blood Purification Products | 3.70B |
| MGI Tech | 3.01B |
| Double Medical Technology | 2.48B |
| APT Medical | 2.41B |
| SonoScape Medical | 2.07B |
| Jafron Biomedical | 2.04B |
| MeHow Innovative | 1.63B |